- Home
- Publications
- Publication Search
- Publication Details
Title
Animal Models of Parkinson’s Disease: A Gateway to Therapeutics?
Authors
Keywords
Parkinson’s disease, animal models, neurotoxins, transgenic, motor symptoms, non-motor symptoms, therapeutics, neuroprotection
Journal
Neurotherapeutics
Volume 11, Issue 1, Pages 92-110
Publisher
Springer Nature
Online
2013-10-24
DOI
10.1007/s13311-013-0234-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions
- (2014) Jarogniew J. Łuszczki Pharmacological Reports
- Spread of neuronal degeneration in a dopaminergic,Lrrk-G2019Smodel of Parkinson disease
- (2013) Samantha J. Hindle et al. Autophagy
- A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent α-Synuclein (α-syn) Aggregation Inhibitor
- (2013) Ronit Shaltiel-Karyo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease
- (2013) Bradley F Boeve LANCET NEUROLOGY
- TheVPS35gene and Parkinson's disease
- (2013) Hao Deng et al. MOVEMENT DISORDERS
- Should clinicians care about preclinical animal research?
- (2013) S. D. Silberberg NEUROLOGY
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
- (2013) Christopher J.R. Dunning et al. Prion
- Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells
- (2013) E. R. Andersson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modeling Parkinson's Disease in Primates: The MPTP Model
- (2013) G. Porras et al. Cold Spring Harbor Perspectives in Medicine
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- F-Box Only Protein 7 Gene in Parkinsonian-Pyramidal Disease
- (2013) Hao Deng et al. JAMA Neurology
- α-Synuclein oligomers and clinical implications for Parkinson disease
- (2012) Lorraine V. Kalia et al. ANNALS OF NEUROLOGY
- Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation
- (2012) Marica Carbone et al. BMC NEUROSCIENCE
- Alterations in axonal transport motor proteins in sporadic and experimental Parkinson’s disease
- (2012) Yaping Chu et al. BRAIN
- Late-onset Parkinsonism in NF B/c-Rel-deficient mice
- (2012) C. Baiguera et al. BRAIN
- A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
- (2012) TT Myöhänen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson’s Disease
- (2012) Zhen Zhang et al. CNS & Neurological Disorders-Drug Targets
- Emerging therapies for Parkinsonʼs disease
- (2012) Werner Poewe et al. CURRENT OPINION IN NEUROLOGY
- Therapies in Parkinsonʼs disease
- (2012) Joseph Jankovic et al. CURRENT OPINION IN NEUROLOGY
- Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
- (2012) Zacharias Kohl et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats
- (2012) Kazuhiro Takuma et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Influence of corticostriatal δ-opioid receptors on abnormal involuntary movements induced by L-DOPA in hemiparkinsonian rats
- (2012) Fabrice Billet et al. EXPERIMENTAL NEUROLOGY
- Animal models of Parkinson’s disease
- (2012) Fabio Blandini et al. FEBS Journal
- The hypoxia imaging agent Cu II (atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease
- (2012) Lin W. Hung et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
- (2012) Kelvin C. Luk et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Plasticity of Subventricular Zone Neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Mouse Model of Parkinson's Disease Involves Cross Talk between Inflammatory and Wnt/ -Catenin Signaling Pathways: Functional Consequences for Neuroprotection and Repair
- (2012) F. L'Episcopo et al. JOURNAL OF NEUROSCIENCE
- Development and Characterization of a New Parkinson's Disease Model Resulting from Impaired Autophagy
- (2012) I. Ahmed et al. JOURNAL OF NEUROSCIENCE
- SIRT1 Protects against -Synuclein Aggregation by Activating Molecular Chaperones
- (2012) G. Donmez et al. JOURNAL OF NEUROSCIENCE
- Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism
- (2012) Xin Yu et al. LIFE SCIENCES
- LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors
- (2012) Kelly M Hinkle et al. Molecular Neurodegeneration
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- Lysosome-dependent pathways as a unifying theme in Parkinson's disease
- (2012) George K. Tofaris MOVEMENT DISORDERS
- A call for transparent reporting to optimize the predictive value of preclinical research
- (2012) Story C. Landis et al. NATURE
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- Animal models of the non-motor features of Parkinson's disease
- (2012) Kimberly McDowell et al. NEUROBIOLOGY OF DISEASE
- Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model
- (2012) Yoshikazu Tasaki et al. NEUROSCIENCE LETTERS
- Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease
- (2012) Avik Roy et al. PLoS One
- -Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
- (2012) M. Decressac et al. Science Translational Medicine
- Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons
- (2011) Nadia Stefanova et al. AMERICAN JOURNAL OF PATHOLOGY
- Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease
- (2011) Anil Kachroo et al. ANNALS OF NEUROLOGY
- Parkinson's Disease: Genetics and Pathogenesis
- (2011) Joshua M. Shulman et al. Annual Review of Pathology-Mechanisms of Disease
- Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease
- (2011) Gokhan K. Ulusoy et al. BRAIN RESEARCH BULLETIN
- Intranasally applied l-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions
- (2011) Owen Y. Chao et al. BRAIN RESEARCH BULLETIN
- Spotlight on Rotigotine Transdermal Patch in Parkinsonʼs Disease†
- (2011) Mark Sanford et al. DRUGS & AGING
- Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria
- (2011) Xiao-xiu Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of LRRK2 kinase dysfunction in Parkinson disease
- (2011) Azad Kumar et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Paraquat induces behavioral changes and cortical and striatal mitochondrial dysfunction
- (2011) A. Czerniczyniec et al. FREE RADICAL BIOLOGY AND MEDICINE
- Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
- (2011) Zhaohui Liu et al. HUMAN MOLECULAR GENETICS
- An effective novel delivery strategy of rasagiline for Parkinson's disease
- (2011) Marcos Fernández et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Phenylbutyrate Up-regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease
- (2011) Wenbo Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhanced Phosphatase Activity Attenuates -Synucleinopathy in a Mouse Model
- (2011) K.-W. Lee et al. JOURNAL OF NEUROSCIENCE
- Lithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease
- (2011) Yong-Hwan Kim et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein
- (2011) Hoa A. Lam et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The effects of pergolide on memory and oxidative stress in a rat model of Parkinson’s disease
- (2011) Alin Ciobica et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Melatonin protects against rotenone-induced cell injury via inhibition of Omi and Bax-mediated autophagy in Hela cells
- (2011) Hongyan Zhou et al. JOURNAL OF PINEAL RESEARCH
- A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline
- (2011) Peter Jenner et al. MOVEMENT DISORDERS
- AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials
- (2011) Daniela Berg et al. MOVEMENT DISORDERS
- Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease
- (2011) Kathleen M. Shannon et al. MOVEMENT DISORDERS
- Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease
- (2011) E.N. Mangano et al. NEUROBIOLOGY OF DISEASE
- Protective Effect of Lycopene on Oxidative Stress and Cognitive Decline in Rotenone Induced Model of Parkinson’s Disease
- (2011) Harpreet Kaur et al. NEUROCHEMICAL RESEARCH
- Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats
- (2011) Tiantian Ren et al. NEUROSCIENCE LETTERS
- Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease
- (2011) Yuncheng Wu et al. NEUROSIGNALS
- Parkinson’s disease: The non-motor issues
- (2011) K. Ray Chaudhuri et al. PARKINSONISM & RELATED DISORDERS
- Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
- (2011) Nian Xiong et al. PLoS One
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- Idebenone and Resveratrol Extend Lifespan and Improve Motor Function of HtrA2 Knockout Mice
- (2011) Ellen Gerhardt et al. PLoS One
- Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3
- (2011) P. M. Rappold et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
- (2010) Thomas G. Beach et al. ACTA NEUROPATHOLOGICA
- Behavioral phenotyping of mouse models of Parkinson's disease
- (2010) Tonya N. Taylor et al. BEHAVIOURAL BRAIN RESEARCH
- Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease
- (2010) Anthony C Vernon et al. BMC NEUROSCIENCE
- Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease
- (2010) PJ Austin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Paraquat and Parkinson's disease
- (2010) C Berry et al. CELL DEATH AND DIFFERENTIATION
- Sleep alterations in an environmental neurotoxin-induced model of parkinsonism
- (2010) Kimberly A. McDowell et al. EXPERIMENTAL NEUROLOGY
- Effect of Cdk5 Antagonist on L-Dopa-Induced Dyskinesias in a Rat Model of Parkinson's Disease
- (2010) Qiang Guan et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on l-DOPA-induced dyskinesia
- (2010) Andrzej Dekundy et al. JOURNAL OF NEURAL TRANSMISSION
- A neuroprotective role for angiogenin in models of Parkinson’s disease
- (2010) Trent U. Steidinger et al. JOURNAL OF NEUROCHEMISTRY
- Proteasome inhibition modeling nigral neuron degeneration in Parkinson’s disease
- (2010) Wenjie Xie et al. JOURNAL OF NEUROCHEMISTRY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
- (2010) Michael S. Okun et al. MOVEMENT DISORDERS
- Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between Parkinson's disease and nonhuman primate brains
- (2010) Raymond T. Bartus et al. MOVEMENT DISORDERS
- Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice
- (2010) Daniel Marcellino et al. NEUROBIOLOGY OF DISEASE
- Genetic Animal Models of Parkinson's Disease
- (2010) Ted M. Dawson et al. NEURON
- MK-801 inhibits l-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism
- (2010) Melanie A. Paquette et al. NEUROPHARMACOLOGY
- Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease
- (2010) Eleni Antzoulatos et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
- (2010) Francisco Pan-Montojo et al. PLoS One
- Effects of Plantago ovata Husk on Levodopa (with Carbidopa) Bioavailability in Rabbits with Autonomic Gastrointestinal Disorders
- (2009) J. J. Garcia et al. DRUG METABOLISM AND DISPOSITION
- Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease
- (2009) James G. Greene et al. EXPERIMENTAL NEUROLOGY
- Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity
- (2009) T. N. Taylor et al. JOURNAL OF NEUROSCIENCE
- Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons
- (2009) B. Kadkhodaei et al. JOURNAL OF NEUROSCIENCE
- Metabotropic Glutamate 7 Receptor Subtype Modulates Motor Symptoms in Rodent Models of Parkinson's Disease
- (2009) B. Greco et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
- (2009) Yanping Li et al. NATURE NEUROSCIENCE
- Tests to assess motor phenotype in mice: a user's guide
- (2009) Simon P. Brooks et al. NATURE REVIEWS NEUROSCIENCE
- Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease
- (2009) Ranjeet Verma et al. NEUROCHEMISTRY INTERNATIONAL
- Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
- (2009) Xian Lin et al. NEURON
- Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease
- (2009) F. Blandini et al. NEUROSCIENCE LETTERS
- Dopamine receptor agonists and depression in Parkinson's disease
- (2009) Marina Picillo et al. PARKINSONISM & RELATED DISORDERS
- A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human α-synuclein A30P+A53T transgenic mice
- (2009) Kazuhiko Ono et al. PARKINSONISM & RELATED DISORDERS
- The selective α1adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease
- (2009) Kerstin Buck et al. SYNAPSE
- The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
- (2008) T. Pan et al. BRAIN
- Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets
- (2008) K.A. Stockwell et al. EXPERIMENTAL NEUROLOGY
- Bladder and bowel dysfunction in Parkinson’s disease
- (2008) R. Sakakibara et al. JOURNAL OF NEURAL TRANSMISSION
- Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration
- (2008) Wen Zhu et al. JOURNAL OF NEUROCHEMISTRY
- Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models
- (2008) Hiroki Takeuchi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4
- (2008) C. M. Niswender et al. MOLECULAR PHARMACOLOGY
- Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism
- (2008) John G. Nutt et al. MOVEMENT DISORDERS
- In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?
- (2007) Marie-Francoise Chesselet EXPERIMENTAL NEUROLOGY
- Selective loss of nigral dopamine neurons induced by overexpression of truncated human α-synuclein in mice
- (2006) Masaki Wakamatsu et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now